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Lactoferrin and lactoferricin 
endocytosis halt Giardia cell 
growth and prevent infective cyst 
production
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Andrea S. Rópolo1 & María C. Touz  1
Lactoferrin (LF) is an 80 KDa iron-binding glycoprotein that plays a significant role in the innate immune 
system and is considered to be an important microbicide molecule. It has been suggested to be effective in 
the treatment of giardiasis, an intestinal disease caused by the protozoan parasite G. lamblia. However, the 
molecular mechanisms by which LF exerts its effect on this parasite are unknown. Most of the microbicidal 
activity of human or bovine LF (hLF or bLF) has been associated with the N-terminal region of the mature LF 
- lactoferricin (LFcin). LFcin is produced by pepsin cleavage of the native protein in vitro and likely in vivo. In 
this work, we analyse the participation of the endocytic machinery of G. lamblia in the internalization of bLF 
and bLFcin and their effects on cell homeostasis. Our results show that, when bLF or bLFcin are internalized 
by receptor-mediated endocytosis, cell growth stops, and morphological changes are produced in the 
trophozoites, which ultimately will produce immature cysts. Our findings contribute to disclose the 
fine mechanism by which bLF and bLFcin may function as an antigiardial molecule and why they have 
therapeutic potential to eradicate giardiasis.
G. lamblia is a protozoan parasite that inhabits the small intestine of humans and other vertebrates causing a 
disease known as giardiasis. Globally, ingestion of G. lamblia cysts, present in water or contaminated food, is the 
most common cause of diarrheal disease not associated with viruses or bacteria, and may affect individuals with 
a normal as well as with an altered immune system. In the environment, G. lamblia is protected by an outer shell 
(cyst wall) that allows it to survive outside the host for long periods of time and makes it tolerant to hypochlorite 
disinfection1,2. Inside the host, the cysts become trophozoites that colonize the intestine and cause the symptoms 
of the disease. As a result of infection, the body’s ability to absorb fat, lactose, vitamin A, and vitamin B12 is 
commonly affected and this may lead to weight loss and can cause malnutrition, especially in children. Only a 
handful of drugs are in use for the treatment of pathogenic protozoan parasites and, in many cases, the infection 
is inevitably fatal without medical intervention3,4. Given that vaccination is not an option for all pathogens and 
that the chronic use of microbicide agents produces resistant strains, there is a critical need for the discovery of 
natural microbicides, as is the case of lactoferrin (LF) and its products. However, this cannot be achieved without 
a better understanding of the basic biology of the parasite, in particular of the processes that may be susceptible 
to therapeutics.
A large amount of research has focused on the structure and function of the iron-binding protein LF, achiev-
ing considerable advances in our understanding of its synthesis, distribution and degradation. It is now recog-
nized as a molecule with multiple biological roles, including regulation of iron absorption, and as a protein with 
anti-oxidant, anti-microbial, anti-carcinogenic and anti-inflammatory functions, among others recently discov-
ered5. Human and bovine milk are the most abundant source of LF but it is also present in saliva, seminal fluid, 
glandular epithelial cells, and neutrophils6,7. It was shown that the degradation of LF to its active peptides, lacto-
ferricin (LFcin) and lactoferrampin, produced during digestion8,9, may be advantageous since the anti-microbial 
effect of these peptides was proved in vitro to be more potent against microorganisms than the native protein10,11. 
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However, it is now known that LF degradation depends not only on its degree of glycosylation (specie-specific) 
and iron saturation but also on the method of administration, intragastric pH, and type and activity of gastric and 
intestinal enzymes, which are highly variable between adults and infants12. Although more and more functions 
are being discovered, the mechanism of the entry of LF (and its peptides) to the cell is not completely clear. New 
candidates involved in this uptake have been postulated. It has been suggested that the multiple biological activi-
ties of LF depend on its target cells and on the presence of specific receptors (LfR) on their surface13–15. However, 
recent evidence showed the participation of the low-density lipoprotein receptor-related protein (LRP) in Lf 
endocytosis by several cell types16–18. This new finding prompted us to analyse whether, in the parasite G. lamblia, 
an LRP-like receptor is involved in the internalization of LF, since no LfR has been found in this parasite but a 
receptor-mediated endocytosis (RME) mechanisms may be involved19–21. On the one hand, Turchany et al. sug-
gested that either human or bovine lactoferrin (as well as their LFcin derivatives) internalization was mediated by 
an unknown receptor and produced irreversible cell damage in the ultrastructure of this parasite19. On the other, 
we reported a few years ago that G. lamblia possesses a RME mechanism for the endocytosis of low-density lipo-
protein (LDL) and chylomicrons via their binding to the giardial GlLRP receptor (GL50803_113565)22–24. Thus, it 
is possible that, in the absence of a bona fide LfR orthologue in the Giardia genome database (GiardiaDB http://
giardiadb.org/giardiadb/), GlLRP is involved in the endocytosis of LF and its derived peptides in G. lamblia.
To analyse whether the internalization of LF could be mediated by RME, we used different strategies to inter-
fere in LF entry at different levels of the endocytosis process. Our hypothesis is that LF enters the trophozoite 
through the GlLRP receptor, competing with LDL and chylomicrons for the receptor and the endocytic machin-
ery. The results display the role of the RME machinery in the regulated endocytosis of bLF and bLFcin and the 
initiation of cell damage that induces cell differentiation but blocks encystation to infective-mature cysts. These 
findings reinforce the use of these molecules as natural killers for giardiasis treatment.
Results
bLF and bLFcin bind to a surface protein receptor. Comparison of the antimicrobial activities of 
human, bovine, murine, and caprine LFcin showed that bovine LFcin was the most potent25. In this work, we 
used bovine apo-LF (containing 4.1% iron) and the iron-free bovine LFcin (bLFcin) since these would be the 
most accessible molecules for therapeutic purposes and showed an equal rate of intake by trophozoites19,20. To 
analyse the entry mechanisms of bLF and bLFcin in healthy cells, we first performed a growth curve of wild-
type trophozoites (strain WB/1267) using different concentrations of bLF and bLFcin, to find the lowest growth 
inhibitory concentration that would allow us to carry out internalization experiments without causing the death 
of the trophozoites. We found that concentrations of 12.5 μM and 2.6 μM of bLF and bLFcin, respectively, were 
sufficient to inhibit cell growth without apparent cell damage or significant killing effect, determined by the cells 
labelled with Trypan blue (Fig. 1A). All the further experiments were performed using these concentrations, 
unless specified.
It was shown that in G. lamblia either hLF or bLF and their peptides remained on the surface of the tro-
phozoites when the cells were maintained at 4 °C, a condition that non-specifically inhibits receptor-mediated 
endocytosis19–21. We first confirmed that both FITC-labelled bLF and bLFcin remained on the trophozoite surface 
in ice-cold medium (0–4 °C) but were observed inside the cell after 30 min of incubation at 37 °C (a situation that 
restored endocytosis) (Fig. 1B). As shown in Fig. 1C, FITC-bLF and FITC-bLFcin were localized in the periph-
eral vacuoles (PVs), organelles that function as endosomes and lysosomes and are located beneath the plasma 
membrane, co-localizing with the PV-marker adaptor protein AP-2. Then, to reveal whether a protein receptor is 
involved, we performed extracellular protease digestion to eliminate the extracellular portion of membrane pro-
teins, before testing bLF and bLFcin binding and internalization. Neither FITC-bLF nor FITC-bLFcin was bound 
to the membrane after protease treatment, while binding and internalization were observed for untreated cells 
(Fig. 1D). This treatment resulted in digestion of the extracellular portion of the variable-surface protein VSP1267 
used as an assay control (Fig. 1D). These results reinforced the participation of a receptor in the endocytosis of 
bLF and bLFcin in G. lamblia. FITC alone was able to enter both untreated and treated cells, as expected (Fig. 1D). 
Protease treatment did not alter the PVs as can been seen by the staining of the PVs by using the anti-AP-2 mAb 
in post-fixed permeabilized cells (Fig. 1D).
GlLRP participates in the endocytosis of bLF and bLFcin. To analyse whether GlLRP is implicated 
in the endocytosis of bLF and bLFcin, we challenged wild-type cells with the GlLRP natural ligand LDL or chylo-
microns before adding different concentrations of FITC-bLF or FITC-bLFcin in a lipoprotein-deficient medium. 
The results showed that the uptake of even up to 25 µM FITC-bLF or 5.2 µM FITC-bLFcin was completely inhib-
ited when the trophozoites were previously incubated with either of the lipoproteins (Fig. 2A). Lipoprotein 
pre-incubation had no effect on FITC internalization (not shown). These results prompted us to determine the 
endocytosis of bLF and bLFcin in cells lacking GlLRP22 to establish a functional connection between GlLRP 
and these molecules. For this, we performed endocytic uptake of FITC-bLF and FITC-bLFcin in wild-type tro-
phozoites (as a control), lrp-ha (cells overexpressing GlLRP-HA), and lrp:as (cells specifically-depleted of GlLRP 
by antisense)22. Before performing the experiments, the relative mRNA expression of the transfected cells was 
analysed as well as the impaired endocytosis of BODIPY-LDL in knock-down trophozoites (Supplementary 
Fig. 1A)22. Fluorescence microscopy showed a significant reduction of both bLF and bLFcin endocytosis in lrp:as 
compared to lrp-ha and wild-type trophozoites (Fig. 2B). Interestingly, growth curves of lrp:as trophozoites under 
bLF or bLFcin treatment showed no effect on cell growth when compared with the lrp:as cells without treatment, 
clearly suggesting that the participation of GlLRP is critical for bLF and bLFcin uptake and microstatic effects 
(Fig. 2C). Conversely, lrp-ha and wild-type trophozoite growth was severely affected by the addition of bLF or 
bLFcin (Fig. 2C). Because lrp:as has a marked effect on cell growth22, each curve was performed independently.
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Figure 1. bLF and bLFcin bind to a protein receptor. (A) Growth curves of wild-type trophozoites (WB/1267) 
with different concentrations of bLF and bLFcin. The number of viable cells was determined by counting 
with a haemocytometer after addition of Trypan blue. Data shown are representative of three independent 
experiments and are expressed as means of triplicates ***p-value < 0.001. (B) FITC-bLF and FITC-bLFcin 
confocal microscopy shows the fluorescence on the trophozoite surface (including the flagella) in ice-cold 
medium (0–4 °C) but inside the cell after 30 min of incubation at 37 °C. (C) FITC-bLF and FITC-bLFcin (green) 
co-localize (yellow in MERGE) with AP-2 (red) at the peripheral vacuoles (PVs). (D) wild-type trophozoites 
show the localization of FITC-bLF and FITC-bLFcin in the PVs (−), beneath the plasma membrane (left 
panels) but, after protease treatment (+), neither FITC-bLF nor FITC-bLFcin is seen inside the cell (right 
panels). The extracellular portion of VSP1267 was degraded and unseen in trophozoites treated with proteases. 
FITC alone was able to penetrate untreated and treated trophozoites. Protease treatment did not distort the PVs 
localization below the plasma membrane (AP-2). Differential interference contrast (DIC) microscopy images 
are shown as insets. Bar, 5 μm.
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The endocytic machinery is involved in bLF and bLFcin uptake. As a strategy to test the partic-
ipation of the clathrin-adaptor proteins GlENTHp (GL50803_3256)26 in the internalization and PV localiza-
tion of bLF and bLFcin, we took advantage of the transgenic cells, glenth-ha (trophozoites overexpressing the 
monomeric clathrin-adaptor protein GlENTHp-HA) and ds-glenth (double-stranded knock-down of GlENTHp) 
(Supplementary Fig. 1B)24. When we added FITC-bLF or FITC-bLFcin to wild-type or transgenic trophozoites, 
we observed a significantly lower internalization of these fluorescent molecules in ds-glenth trophozoites com-
pared to wild-type or glenth-ha transgenic trophozoites (Fig. 3A). Binding assay showed that FITC-bLF and 
FITC-bLFcin were located on the surface of the trophozoites at 4 °C, indicating that the receptor-binding also 
occurred in these transgenic cells (Fig. 3A, top inserts). When we tested the effect of bLF and bLFcin treatment 
on these cells in 48 h cultures, their addition produced a marked cytostatic effect on wild-type (Fig. 2C) and 
glenth-ha transgenic trophozoites but not on ds-glenth cells (Fig. 3B), reinforcing the fact that the entry of bLF and 
bLFcin by RME is necessary to produce the cytotoxic effect. Similar to what occurs with lrp:as, the depletion of 
Figure 2. GlLRP is involved in the endocytosis of bLF and bLFcin. (A) Wild-type G. lamblia trophozoites 
challenged with unlabelled LDL (+) or chylomicrons (+) show a reduction of FITC-bLF and FITC-bLFcin 
uptake compared with unchallenged trophozoites (−). The most representative effect is shown for each 
treatment. (B) FITC-bLF and FITC-bLFcin are endocytosed to the PVs in wild-type and lrp–ha but not in lrp:as 
trophozoites. The most representative effect is shown for each type of cell. Differential interference contrast 
microscopy images are shown as insets. Bars, 5 μm. Histograms of fluorescent images (fluorescence/area × 
103) show the relative amount of fluorescent bLF or bLFcin internalized by parasites in control (wild-type) and 
transgenic cells (lrp–ha and lrp:as). All images were equally processed; the threshold value was determined 
and is exclusive in each image. The results are presented here as the average (±SD) of 10 determinations. (C) 
lrp:as transgenic trophozoites treated with 12.5 μM of bLF or 2.6 μM of bLFcin show a non-deleterious effect 
on cell growth compared with wild-type and lrp-ha cells. Data shown are representative of three independent 
experiments and are expressed as means of triplicates ***p-value < 0.001.
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GlENTHp causes significant harm to trophozoite growth24 and, thus, each curve was performed independently. 
The toxicity effect of bLF and bLF-cin on overexpressing lrp-ha transgenic cells seemed to be more drastic than 
on the wild-type and glenth-ha cells, suggesting that more expression of the receptor lead an augment in bLF and 
bLF-cin internalization and toxicity. Altogether, these results show the participation of GlLRP and the endocyto-
sis machinery in the internalization of bLF and bLFcin at low doses. As the internalization of human and bovine 
LF and their peptides produced strong cell damage and killing effects at high doses19–21, we examined whether 
there is any effect of these molecules at the low doses tested in this work.
Low concentrations of bLF and bLFcin altered the homeostasis of the trophozoites. It has been 
shown by Turchany et al. (1997) and Aguilar-Diaz et al. (2016) that bLF and bLFcin produce a variety of mor-
phologic effects on treated trophozoites, ranging from changes in the cytoskeleton to endomembrane structures, 
including marked vesiculation of the endoplasmic reticulum (ER), enlargement of the nuclear envelope and delo-
calization of the PVs containing electron-dense material19–21. These alterations seem to be a clear effect of the start 
of cellular necrosis, as a cause of the high concentration of LF and LFcin used in these assays. Since no studies 
have been made of morphological defects using low concentrations of these molecules, we decided to analyse first 
whether the PVs were altered after treatment with bLF and bLFcin. The character of PVs as an acidic compart-
ment was assessed by adding the fluorescent cell-permeant weak base LysoTracker, a molecule that specifically 
Figure 3. The clathrin-adaptor protein GlENTHp participates in bLF and bLFcin uptake. (A) FITC-bLF and 
FITC-bLFcin are endocytosed to the PVs in wild-type and glenth–ha but not in ds-glenth trophozoites. The 
most representative effect is shown for each type of cell. Differential interference contrast (DIC) microscopy 
images are shown as insets. Bars, 5 μm. Representative image of wild-type and transgenic trophozoites showing 
the binding of FITC-bLF and FITC-bLFcin on the cell surface (including the flagella) when treated 10 min at 
4 °C, washed and fixed with 4% formaldehyde (top insets). Histograms of fluorescent images (fluorescence/
area × 103) show the relative amount of fluorescent bLF or bLFcin internalized by parasites in control (wild-
type) and transgenic cells (glenth–ha and ds-glenth). All images were equally processed; the threshold value 
was determined and is exclusive in each image. The results are presented here as the average (±SD) of 10 
determinations. (B) ds-glenth transgenic trophozoites treated with 12.5 μM of bLF or 2.6 μM of bLFcin show 
a non-deleterious effect on cell growth compared with glenth-ha cells. Data shown are representative of three 
independent experiments and are expressed as means of triplicates ***p-value < 0.001.
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labels acidic compartments like the PVs and including the bare zone (Fig. 4A, mock-treated)23,27. Intriguingly, 
we found the ER acquired acidic characteristics when the cells were treated with low concentrations of bLF or 
bLFcin (Fig. 4A). Still, FITC-bLF and FITC-bLFcin localized inside the PVs (Fig. 4B). The proper localization 
of the PVs after FITC-bLF and FITC-bLFcin treatment was also assessed by using the 2F5 mAb, which detects 
the PV-resident protein AP-223 (Fig. 1C). Thus, at low concentration, these molecules seemed not to disrupt 
PVs localization but rather altered the acidity of the ER by an unknown mechanism. To analyse this further, we 
prepared the trophozoites for transmission and scanning electron-microscopy (TEM and SEM). Under the same 
treatment, the trophozoites showed more electron-dense PVs and the appearance of dilated ER membranes form-
ing clefts (Fig. 5). When treated trophozoites were observed under SEM, they exhibited plasma membrane invag-
inations and protrusions with no perforations or holes observed on the membrane, compared with untreated 
trophozoites (Fig. 6). These observations showed that, at low concentrations, bLF and bLFcin did not produce 
severe morphological alterations of the trophozoites. However, they caused dilation of the ER membranes (clefts), 
Figure 4. bLF and bLFcin cell treatment produce acidification of the ER. (A) Addition of LysoTracker (red) 
to wild-type trophozoites treated with 12.5 μM of FITC-bLF or 2.6 μM of FITC-bLFcin shows acidification of 
the ER. In mock-treated wild-type trophozoites, only the acidic PVs, including the bare zone (arrowhead), are 
labelled with LysoTracker. Insets show the staining intensity transformed into a Fire Lookup Table with the 
ImageJ program (colour bar), in which fluorescence intensity increases from black (0) to white (255) (middle 
panels) and deconvolution using Super-resolution radial fluctuations, in which the reticular network of the ER 
is clearly denoted in treated cells (bottom panels). (B) Same images showing that FITC-bLF and FITC-bLFcin 
are located in the PVs (green) after treatment. Bars, 10 μm.
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expansion of the nuclear membrane and plasma membrane protrusions, events also described during the first 
step of cell differentiation into cysts28–30.
bLF and bLFcin activate cell differentiation. We wondered whether low doses of bLF and bLFcin 
might mimic the trigger that induces the differentiation to cyst. Encystation begins in response to changes in the 
trophozoite environment, including increased bile concentrations, alkaline pH and depletion of cholesterol31. 
As a consequence, the proteins that will form the cyst wall (CWP1-3, cyst wall proteins 1 to 3) are specifically 
synthesized and transported into encystation-specific vesicles (ESVs) to reach the plasma membrane (Fig. 7A). 
Similarly, the addition of bLF or bLFcin to growing trophozoites, maintained in Labeling buffer lacking serum for 
30 min, washed with the same medium without bLF or bLFcin at 4 °C and immediately fixed using 4% formal-
dehyde, promoted the expression of CWP1 and the formation of ESVs. Moreover, we observed that the number 
of trophozoites containing ESVs increased with the addition of increased amounts of bLF or bLFcin (Fig. 7B). 
Mock-treated trophozoites processed equally did not show CWP1 expression or ESVs formation, suggesting that 
Figure 5. bLF and bLFcin cause morphological subcellular alterations on trophozoites. Electron microscopy 
shows G. lamblia trophozoites without addition of bLf or bLFcin (a) and trophozoites treated with 12.5 μM of 
bLF (b,c), or 2.6 μM of bLFcin (d,e). Insets show alteration of the electron-dense material of the PVs (PV), clefts 
formed by ER opening (white *), and nuclear membrane expansion only in treated cells (b’–d’) but not in the 
control (a’). A more drastic effect on the ER is observed in cells treated with bLFcin (e, black *). N: nucleus. PVs: 
Peripheral Vacuoles. Bar sizes are depicted in each figure.
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treatment with bLF or bLFcin is responsible for CWP1 expression (Fig. 7B, mock-treated). No cysts-like cells 
were observed at any treatment concentration and these trophozoites remained as encysting-like cells for more 
than 24 h (not shown). Trophozoites encysting for 12 h (12 h.p.i) were tested as control of the immunofluores-
cence assay.
bLF and bLFcin produce futile cysts. The fact that the expression of CWPs and formation of ESVs is 
necessary but not sufficient to produce mature-infective cysts, and no cysts were observed after adding low doses 
of bLF or bLFcin, prompted us to analyse whether the addition of bLF and bLFcin might favor the production of 
viable cysts when exposed to normal encystation conditions (encysting medium). We performed the in vitro high 
bile Uppsala encystation protocol32 to induce cyst production from trophozoites but now adding bLF or bLFcin, 
and used non-treated trophozoites as control. After 48 h of encystation, the number of cysts produced by treated 
cells was significantly lower than that of non-treated control cells (Fig. 8A). Moreover, treated cells produced 
unviable cysts-like cells, since these cysts were not water-resistant (Fig. 8B). Since the transmission of G. lamblia 
is primarily due to the presence of mature water-resistant and biologically active cysts in contaminated water 
supplies, the inhibition of trophozoite growth and the production of non-viable cysts by bLF and bLFcin make 
these natural molecules excellent candidates for controlling giardiasis.
Discussion
This report showed that low concentrations of both bLF and bLFcin produced growth inhibition of G. lamblia tro-
phozoites and triggered incomplete cell differentiation. Previous reports showed the killing effect of high concen-
trations of both molecules in G. lamblia trophozoites by causing severe morphological defects19–21, and suggested 
but did not demonstrate the implication of a receptor and the participation of the endocytosis machinery19–21. In 
G. lamblia, we previously reported that GlLRP participates in the binding and internalization of LDL and chylo-
microns through a RME mechanism involving the adaptor proteins AP-2 and GlENTHp23,24. Here, we showed 
that, similar to what happened in other cells, bLF and bLFcin are internalized through the same pathway and 
that this mechanism is essential to trigger morphological changes and microstatic effects in treated trophozoites. 
This evidence also reinforces the findings that, in eukaryotic cells, the internalization of bLFcin depends on an 
energy-dependent pathway that is inhibited at 4 °C, and differs from the energy-independent mechanisms in 
which LFcin directly interacts with the plasma membrane producing membrane permeabilization and cell death 
in bacteria33. In this regard, Zumthor et al. 2017, showed the presence of static invaginations containing the giar-
dial clathrin heavy chain that connect the space between the PM and the PV and suggested that they might func-
tion as unregulated points of extracellular material entry to the cell34. However, the role of these static structures 
is still unclear as was addressed by us in a previous publication35. It is possible that the clathrin heavy chain in 
this parasite also participates in the unregulated entry of material from the environment. Still, the critical exper-
iment including depletion of clathrin to test for defects in endomembrane organization and RME has yet to be 
performed. There is extensive evidence that GlENTHp and the clathrin heavy chain are involved in the canonical 
RME machinery23,24,36,37. However, data from the group headed by Dr. Adrian Helh suggested that GlENTHp 
(named GlEpsin by this group) does not participate in RME because of its localization on the giardial ventral disk 
and the lack of evidence of GlEpsin interaction with endosomal components, including clathrin26. The differ-
ences between their data and others (including us) has been well addressed in several publications24,35,38–40. So far 
only LDL, chylomicrons and (now) bLF and bLFcin was proved to be endocytosed by RME, with the canonical 
machinery involved23,24,36,37.
More than 7000 articles describing the characterization and properties of LF from many origins have been 
posted in biomedical and life sciences journal databases. LF has been intensively studied as an iron-transferring 
molecule promoting iron absorption, mostly through its binding to specific LF receptors present in human 
mucosa cells41–44. Nevertheless, many other properties and particularities of LF have been discovered, such as its 
immunomodulatory, microbicidal, anti-inflammatory, and anti-carcinogenic activities45. LF can exist in nature 
in an iron-free form known as apoLF and as holoLF, with at least one of the two ferric ions attached. Although 
both types of lactoferrin interact with pathogenic microorganisms, apoLF can be microbicidal while holoLF can 
be used by bacteria, fungi and protozoa as a source of iron for growth46–48. One of the hypotheses was that the 
microbicidal effect of LF relied on its iron-binding capacity, withholding iron required by the microorganisms. 
Figure 6. Plasma membrane deformations are caused by bLF and bLFcin at low concentrations. Scanning 
electron microscopy of wild-type trophozoites without addition of bLf or bLFcin (A) shows intact, smooth 
plasma membrane, while trophozoites treated with 12.5 μM of bLF (B), or with 2.6 μM of bLFcin (C), 
show membrane invaginations (*) and protrusions (arrowhead) but not holes or perforations. The most 
representative picture is shown for each type of cell. Bars, 2 μm.
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However, the microbicidal action of LF on many microorganisms is stronger than iron deprivation itself and the 
addition of iron did not prevent killing49–51. Moreover, most of the bactericidal activity of hLF and bLF has been 
attributed to the iron-free N-terminal peptides of mature LF (human LFcin residues 1–47 and bLFcin residues 
17–41), produced by pepsin cleavage of the native protein in vitro and probably in vivo8,9,11. Importantly, LFcin 
has more potent microbicidal activity in vitro than intact bLF (on a molar basis)8,9,11. In this context, it is clear that 
LF degradation may have beneficial protective functions rather than detrimental. However, as the degradation of 
LF depends on its source species, the temperature, the pH and the activity of enzymes, it is necessary to validate 
its action in different conditions to provide essential information.
Figure 7. Addition of bLF and bLFcin to growing wild-type trophozoites induces CWP1 expression and ESVs 
formation. (A) The encystation process: Immunofluorescence assays and confocal microscopy show that CWP1 
(in green) is not expressed on non-encysting trophozoites but appeared in de novo formed ESVs after 6 hours 
post-induction (h.p.i.) of encystation. Finally, CWP1 is released to constitute the cyst wall (cyst). Bar, 5 μm. 
(B) After treatment, CWP1 is observed in trophozoites exposed to different concentrations bLF or bLFcin in 
Labeling buffer lacking serum for 30 min. No CWP1 signal is detected in mock-treated growing trophozoites. 
Trophozoites encysting for 12 h (12 h.p.i) are shown as control of the IFA. Bar, 5 μm. (C) The graphics show 
the percentage of trophozoites with formed ESVs which increases as we raise the dose of bLF or bLFcin. 
Data shown are representative of three independent experiments and are expressed as means of triplicates 
***p-value < 0.001, **p-value < 0.01, and *p-value < 0.05.
www.nature.com/scientificreports/
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Holo-human LF is endocytosed by its binding to the specific LfR present in the apical membrane of the intes-
tinal cell and this uptake, together with the later iron release pathway, is part of the regulation of iron metabolism 
and iron content in the human body44. On the other hand, additional multifunctional properties of LF have been 
attributed to its binding to LRP receptors52. Unfortunately, the direct interaction of bLF and bLFcin with GlLRP 
was problematic since we were unable to successfully test this interaction by immunoprecipitation or pull-down 
using crosslinkers (Supplementary Fig. 2). However, few if any reports on LF showed direct interaction with a 
receptor but rather assessed their interaction indirectly, as we demonstrated in this report.
The effect of LF binding to LRP induces different signalling pathways depending on the target cells53. Thus, 
in the Giardia trophozoites treated with bLF and bLFcin, their interaction with GlLRP may be responsible for 
the signalling that induces the beginning of the encystation process. The participation of GlLRP in signalling 
has not yet been addressed but it may complete the already proposed mechanism of cholesterol-mediated reg-
ulation of encystation induction, in which the MAPK/ERK signalling pathway seems to be responsible54. Our 
results showing that low concentrations of bLF or bLFcin promoted the expression of CWP1, suggest that there 
may be a signal mechanism that triggers CWP expression. However, this signalling seems to differ with the one 
involved in triggering the encystation process since treated trophozoites were unable to differentiate into mature 
water-resistant cysts. This finding agrees with the data showing that not only the expression of CWPs but also 
the coordinated trafficking and deposition to form the cyst wall seems to be necessary to produce viable cyst55–58. 
Unexpectedly, the ER turned acid after bLF or bLFcin addition to trophozoites. The PVs and the PV-containing 
bare zone have been the only acidic organelles described in G. lamblia23,59. However, in the report of Ratner 
et al., 2008, although they stated that LysoTracker stained lysosomal vesicles (PVs), an image showed a typical ER 
pattern after addition of the plant lectin wheat germ agglutinin (WGA) to growing cells60. It is possible that the 
addition of WGA to growing trophozoites had a similar effect (ER stress??) than bLf or bLFcin. Since this experi-
ment lacked the control in which cells without addition of WGA were stained with Lysotracker, a straight forward 
interpretation of the images would be inappropriate. We also found that trophozoites treated with low doses of 
Figure 8. Treated trophozoites are unable to produce mature cysts. (A) Trophozoites exposed to 12.5 μM of 
bLF or 2.6 μM of bLFcin during encystation show a significant reduction in the percentage of cyst-like cells, 
compared with the non-treated control. (B) Bars show that the percentage of the cysts produced by cells treated 
with 12.5 μM of bLF or 2.6 μM of bLFcin is less than 8% water-resistant when compared with the control of non-
treated encysting (48 h.p.i.) cells.
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bLF or bLFcin were still unable to differentiate into viable cyst when were placed in the encystation medium, 
suggesting that bLF and bLFcin produce an alteration of the differentiation process by un still unexplored mecha-
nism. Several studies reported that changes in the pH, bile salts and cholesterol in the trophozoites’ environment 
are key requirements for the differentiation of trophozoites into water-resistant cysts54,61. It is well known that 
regulation of the internal pH of endomembrane compartments is required for their optimal function62. It is thus 
possible that the immature cysts could result from defects in the CWP trafficking due to disrupted endomem-
brane pH in bLf and bLfcin treated trophozoites. A detailed analysis of the intracellular pH variation during 
the parasite differentiation might help to understand the cellular homeostasis that occurs during encystation. A 
deeper analysis comparing the signalling, protein expression and trafficking between treated and untreated cells 
induced to encyst is necessary to disclose this matter. However, the fact that a low amount of bLF or bLFcin avoids 
the dissemination of the diseases by producing non-viable cyst is promising.
The unique characteristics of LF and its derived peptides provide an opportunity for treatment and nutritional 
improvements. It can be used as a supplement to increase iron absorption and free radical detoxification, since it 
was found that the iron from bLF was more easily absorbed across the intestinal mucosa than the iron from fer-
rous salts63. But, in addition to iron uptake, the benefits of its antimicrobial and regenerative activity give LF great 
therapeutic potential. In this scenario, our work supports the use of bLF to treat giardiasis. It may be beneficial in 
several aspects: at high doses it produces trophozoite killing, while traces (low concentration) cause microstatic 
effects associated with the production of cyst-like cells; LF protects the intestinal cell barrier64 and modulates the 
immune response65,66; and, finally, no side effects of the use of LF as a dietary supplement have been reported 
to date67. The current antigiardial therapy of choice is with nitroimidazoles, but the number of refractory cases, 
usually associated with drug resistance, suboptimal drug concentrations and immunocompromise, is increas-
ing68,69. There are also frequent side effects associated with these drugs, including dizziness, trouble sleeping and 
severe gastrointestinal symptoms. It is clear that new potential pharmaceuticals from natural sources need to be 
evaluated to improve the chemotherapy treatment for giardiasis. The properties established for LF give it great 
therapeutic potential.
Materials and Methods
Antibodies and other reagents. Fluorescein isothiocyanate (FITC) conjugated anti-CWP1 mon-
oclonal antibody (mAb) was purchased from Waterborne Inc. (New Orleans, LA, USA). 2F5 mAb was used 
for the μ2 subunit of AP-223. Anti-VSP1267 5C1 mAb was a gift of Dr. Nash70. Anti-HA mAb, Apo-lactoferrin 
containing 4.1% iron, from bovine milk (bLF), poly-L-Lysine, formaldehyde, cysteine hydrochloride mono-
hydrate, bovine serum albumin and low-density lipoprotein (LDL) from human plasma were purchased from 
Sigma-Aldrich (St. Louis, MO). FluorSave™ reagent was from Calbiochem (San Diego, CA). Human chylo-
microns were acquired from Athens Research & Technology (Athens, GA, USA). LysoTracker™ Red DND-99 
used to label PVs was acquired from Molecular Probes-Invitrogen (Carlsbad, CA). FITC-(N-Terminal) bLFcin 
(FKCRRWQWRMKKLGAPSITCVRRAF) was synthesized and labelled by GenScript® (Piscataway, NJ, USA). 
For FITC-Labeling bLF, 2 mg/mL of bLF was dissolved in 0.1 M sodium carbonate buffer pH 9 and incubated 
overnight with FITC (Sigma-Aldrich, St. Louis, MO). Then, 50 mM NH4Cl was added for 2 hours at 4 °C to stop 
the reaction. The unbound FITC was eliminated by dialysis using cellulose membranes (Sigma-Aldrich, St. Louis, 
MO) at 4 °C.
Giardia cell lines. Standard cell lines: Wild-type trophozoites of the isolate WB, clone 126771. Stable trans-
fected cells: lrp-ha: puromycin resistant WB1267 overexpressing the HA C-terminus tagged GlLRP; lrp:as puro-
mycin resistant WB1267 overexpressing antisense lrp RNA for GlLRP depletion22. glenth-ha: puromycin resistant 
WB1267 overexpressing the HA C-terminus tagged GlENTHp; ds-glenth: puromycin resistant WB1267 over-
expressing Tetracycline-inducible glenth double stranded RNA (ds) for GlENTHp knock-down24. Trophozoites 
were cultured in TYI-S-33 medium supplemented with 10% adult bovine serum and 0.5 mg/mL bovine bile as 
described previously72.
Growth curves. Growth curves were performed as previously described23. Briefly, the indicated cell lines 
were grown exponentially in 8-mL tubes with different μM concentrations of bLF or bLFcin (described in the cor-
responding figure legends) and cellular proliferation/viability measured at 6-, 12-, 24- and 48-h after treatment. 
The number of viable cells was determined by counting with a haemocytometer after addition of 0.4% Trypan 
blue, according to the instructions from the manufacturer. Results were analysed for statistical significance by 
two-way ANOVA with GRAPHPAD Prism 5 Data Analysis Software (GRAPHPAD Software Inc., La Jolla, CA, 
USA). Mean and standard mean values were calculated from at least three biologically and technically independ-
ent experiments. p < 0.001 was considered significant and was indicated by asterisks in the figures.
Uptake experiments. The uptake assays were performed as reported23. Briefly, wild-type, lrp-ha, lrp:as, 
glenth–ha or ds-glenth trophozoites were incubated (or not, for control) with bLF or bLFcin in Labeling buffer 
(50 mM Glucose, 10 mM L-cysteine and 2 mM Ascorbic Acid in PBS, pH 7.2) at 4 °C, washed and placed at 37 °C 
for 30 min to allow the endocytosis. The trophozoites were then washed, fixed with 4% of formaldehyde and 
visualized by fluorescence microscopy. Fluorescence images were measured by the Fiji image processing package 
(http://fiji.sc/wiki/index.php/Fiji) over raw images of each cell. All images were acquired and processed identi-
cally. Competition binding assays were performed by growing wild-type cells in the presence of a 10-fold excess 
(100 μg/mL) of unlabelled LDL or 100 μg/mL chylomicrons for 20 min in ice-cold Labeling buffer (0–4 °C). Then, 
the cells were washed and incubated with 25 µM FITC-bLF or 5.2 µM FITC-bLFcin first in ice-cold Labeling 
buffer, washed, and later maintained at 37 °C for 30 min for endocytosis. Cells were then harvested and fixed with 
4% formaldehyde. All washes were performed twice by centrifugation at 600 × g with Labeling buffer at 4 °C. 
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Preparations were mounted with FluorSave™ mounting medium and the fluorescence analysed with a motorized 
FV1000 Olympus confocal microscope (Olympus UK Ltd, UK), using 63x or 100x oil immersion objectives (NA 
1.32).
Extracellular protease digestion. 5 × 105 cells were incubated with 300 µg of Proteinase K (Productos 
Bio-Lógicos, IA09) and 600 µg of Trypsin from porcine pancreas (Sigma Chemical Co, USA) in buffer (50 mM 
Tris, 7.5 mM CaCl2, pH 8.8). Control trophozoites were incubated with the buffer without proteases. The cells were 
treated for 3 h at 37 °C with gentle mixing. Then, to inactivate the proteases, 20 µl of 0.1 M Phenylmethanesulfonyl 
fluoride (PMSF) was added. After treatment, 0.4% Trypan blue was added to corroborate plasma membrane 
integrity. The trophozoites were washed with PBS at 37 °C and incubated in Labeling buffer containing 12.5 µM 
of FITC-bLF, 2.6 µM of FITC-bLFcin, or 50 µg of FITC for 30 min at 37 °C. After washing the cells, they were 
attached to slides pretreated with poly-L-Lysine and fixed with 4% formaldehyde for 40 min at room temperature. 
Protease-treated and untreated control trophozoites were subjected to immunofluorescence assay as described 
below, using the anti-VSP1267 5C1 mAb without permeabilization or the anti-AP2 mAb 2F5 in fixed-Trito X-100 
permeabilized cells.
Immunofluorescence Assay (IFA). IFA of fixed cells was performed basically as described73. Briefly, tro-
phozoites or encysting cells were cultured in growth medium or encysting medium, respectively, harvested and 
allowed to attach to slides, pretreated with poly-L-lysine. After fixation with 4% formaldehyde in PBS, the cells 
were washed and blocked with 3% BSA (Sigma Chemical Co, USA) in 0.01% Saponin in PBS. Cells were then 
incubated with the primary Ab diluted in PBS containing 1.5% BSA and 0.01% Saponin at 37 °C, followed by 
incubation with Alexa 488 anti-mouse (dilution 1:500) secondary antibody at 37 °C. Finally, preparations were 
washed with PBS and mounted in FluorSave™ mounting medium. Fluorescence staining was visualized with 
a motorized FV1000 Olympus confocal microscope (Olympus UK Ltd, UK), using 63x or 100x oil immersion 
objectives (NA 1.32). Differential interference contrast images were collected simultaneously with the fluores-
cence images, by the use of a transmitted light detector. Images were processed using Fiji software74.
LysoTracker staining. The staining was performed as previously described27. Trophozoites, untreated or 
treated with 12.5 µM of bLF or 2.6 µM of bLFcin, were incubated at 37 °C for 30 min in growth medium containing 
50 nM LysoTracker Red. After this treatment, the trophozoites were observed by video microscopy as described 
previously30.
Image processing for stacks. For live cells stained with LysoTracker, stacked images were acquired at 
10 f.p.s. Super-resolution radial fluctuations (SRRF) frames were produced by running the NanoJ-SRRF method, 
as described75.
Transmission electron microscopy (TEM). 4 × 107 wild-type trophozoites were incubated with 12.5 µM 
of bLF or 2.6 µM of bLFcin for 30 min at 37 °C. The trophozoites were washed twice with PBS at 37 °C and then 
fixed in a solution containing 2.5% glutaraldehyde, 4% paraformaldehyde, and sucrose 4% in 0.1 M cacodylate 
buffer. The cells were centrifuged for 5 min at 600 × g, washed in 0.1 M cacodylate buffer and postfixed for 60 min 
at room temperature in a solution containing 1% osmium tetroxide, 0.8% potassium ferrocyanide, and 5 mM 
CaCl2 in 0.1 M cacodylate buffer. Subsequently, the cells were washed in buffer, dehydrated in acetone and embed-
ded in Polybed resin. Thin sections were stained with uranyl acetate and lead citrate and observed in a JEOL 1230 
Transmission Electron Microscope.
scanning electron microscopy (sEM). 1 × 107 wild-type trophozoites were incubated with 12.5 µM of 
bLF or 2.6 µM of bLFcin for 30 min at 37 °C. Samples were fixed and postfixed as described for TEM, dehydrated 
in ethanol series, dried by the critical point method in a Leica (EM CPD 030) apparatus, mounted on stubs, and 
covered with a 20 nm-thick gold layer in a Denton vacuum (desk IV) equipment. The samples were observed in a 
JSM-6390LV scanning electron microscope.
bLF or bLFcin treatment and differentiation. Growing wild-type cells were incubated with increas-
ing concentrations of bLF or bLFcin for 30 min at 37 °C in Labeling buffer (50 mM Glucose, 10 mM L-cysteine 
and 2 mM Ascorbic Acid in PBS, pH 7.2). After two 5 min wash of the cells with Labeling buffer alone (0–4 °C), 
the cells were harvested, fixed immediately with 4% formaldehyde and prepared for direct immunofluores-
cence as described above but using the FITC-labelled anti-CWP1 mAb. Control of the experiment included the 
mock-treatment of growing wild-type trophozoites to compare with the effect of bLF and bLFcin addition, and of 
wild-type trophozoites after 12 hour post-induction (h.p.i.) of encystation, as a control for IFA.
Encystation of bLF and bLFcin treated trophozoites. 5000 trophozoites/ml were induced to encyst 
with 12.5 µM of bLF or 2.6 µM of bLFcin (or without bLF or bLFcin for control of non-treated encysting cells). 
The same amount of growing cell were led to attach before addition of the encystation TYI-S33 medium, supple-
mented with 10% adult bovine serum and 2.5–5.0 mg/ml bovine bile at pH 7.832.
Water-treatment. Cysts and cyst-like cells obtained after bLF or bLFcin treatments were harvested and the 
remaining trophozoites lysed by incubation in double-distilled water for 48 h at 4 °C. Water-resistant cysts were 
washed 3 times and counted with a haemocytometer.
Data Availability statement
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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